GH Research PLC (GHRS)
11.70
+0.02
(+0.17%)
USD |
NASDAQ |
May 06, 12:24
GH Research Enterprise Value: 446.13M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 446.13M |
| May 02, 2024 | 420.63M |
| May 01, 2024 | 460.18M |
| April 30, 2024 | 408.67M |
| April 29, 2024 | 397.74M |
| April 26, 2024 | 385.26M |
| April 25, 2024 | 384.74M |
| April 24, 2024 | 414.91M |
| April 23, 2024 | 426.36M |
| April 22, 2024 | 448.21M |
| April 19, 2024 | 412.31M |
| April 18, 2024 | 420.63M |
| April 17, 2024 | 410.23M |
| April 16, 2024 | 410.23M |
| April 15, 2024 | 448.21M |
| April 12, 2024 | 420.63M |
| April 11, 2024 | 410.75M |
| April 10, 2024 | 413.35M |
| April 09, 2024 | 415.43M |
| April 08, 2024 | 413.87M |
| April 05, 2024 | 418.03M |
| April 04, 2024 | 411.79M |
| April 03, 2024 | 410.23M |
| April 02, 2024 | 412.83M |
| April 01, 2024 | 414.91M |
| Date | Value |
|---|---|
| March 28, 2024 | 393.06M |
| March 27, 2024 | 395.66M |
| March 26, 2024 | 415.43M |
| March 25, 2024 | 387.34M |
| March 22, 2024 | 398.78M |
| March 21, 2024 | 389.42M |
| March 20, 2024 | 410.75M |
| March 19, 2024 | 405.03M |
| March 18, 2024 | 400.86M |
| March 15, 2024 | 405.55M |
| March 14, 2024 | 367.57M |
| March 13, 2024 | 374.33M |
| March 12, 2024 | 319.70M |
| March 11, 2024 | 273.39M |
| March 08, 2024 | 260.39M |
| March 07, 2024 | 264.03M |
| March 06, 2024 | 278.60M |
| March 05, 2024 | 280.68M |
| March 04, 2024 | 261.43M |
| March 01, 2024 | 280.68M |
| February 29, 2024 | 300.45M |
| February 28, 2024 | 266.63M |
| February 27, 2024 | 292.12M |
| February 26, 2024 | 256.23M |
| February 23, 2024 | 228.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
112.35M
Minimum
Dec 18 2023
1.171B
Maximum
Nov 09 2021
453.22M
Average
385.26M
Median
Apr 26 2024
Enterprise Value Benchmarks
| Amarin Corp PLC | 44.57M |
| Jazz Pharmaceuticals PLC | 10.83B |
| Prothena Corp PLC | 612.98M |
| Iterum Therapeutics PLC | 20.69M |
| Mural Oncology PLC | -206.04M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.27M |
| Total Expenses (Quarterly) | 11.16M |
| EPS Diluted (Quarterly) | -0.21 |
| Earnings Yield | -5.81% |